Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter.

Slides:



Advertisements
Similar presentations
The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Advertisements

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter.
Renal Function Testing
Uric Acid and Long-term Outcomes in CKD
KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD  Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,
Lilia Cervantes, Monica Grafals, Rudolph A. Rodriguez 
Diagnosis and Treatment of Hyponatremia
Peritoneal dialysis American Journal of Kidney Diseases
Susan P.Y. Wong, MD, Ann M. O'Hare, MD, MA 
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD 
A Decade After the KDOQI CKD Guidelines
The US Renal Data System “Pie Chart of Death”
Joseph A. Vassalotti, MD, Beth Piraino, MD, Lynda A. Szczech, MD 
Estevão Bassi, MD, Cesar B
Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective  J. Michael Lazarus, MD, Raymond M. Hakim,
Sevelamer Prescriptions After Reporting of the Dialysis Clinical Outcomes Revisited (DCOR) Trial Findings: An Analysis of 5,495 Patients Receiving Maintenance.
Evaluation of the Potential Living Kidney Donor
Hai-yan Wang, MD, American Journal of Kidney Diseases
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Accountable Care Organizations and ESRD: The Time Has Come
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Wayne Trebbin, MD, Peter Monteleone, MD 
Salt and Hypertension American Journal of Kidney Diseases
Guidelines for the Older Adult With CKD
Prehypertension and Incidence of ESRD: A Systematic Review and Meta-analysis  Yuli Huang, MD, Xiaoyan Cai, MD, Jianyu Zhang, MD, Weiyi Mai, MD, PhD, Sheng.
Lifetime Incidence of CKD Stages 3-5 in the United States
In Reply to ‘The US Renal Data System “Pie Chart of Death”’
Volume 64, Issue 5, Pages (November 2003)
Dorothea Nitsch, MD, MSc  American Journal of Kidney Diseases 
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS 
A Decade After the KDOQI CKD Guidelines: A Historical Perspective
A New Era of Renal Denervation Trials for Patients With Hypertension?
Neonatal Acidosis With Nephrocalcinosis: A Clinical Approach
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Prediabetes as a Precursor to Diabetic Kidney Disease
Julie A. Wright Nunes, MD, MPH, Kerri L
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study  Eric D.
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
Kidney Disease Among African Americans: A Population Perspective
American Journal of Kidney Diseases
Quiz Page April 2008 American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
Drug Dose Adjustments in Patients With Renal Impairment
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Risk for Incident Renal Dialysis in a Managed Care Population
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Trial Quality in Nephrology: How Are We Measuring Up?
Removal of Dabigatran by Hemodialysis
Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm  David P. Calfee, MD, MS  American Journal of Kidney.
Making Music American Journal of Kidney Diseases
Kidney Failure Treatment: The Freedom to Choose
The Use of Vaccines in Adult Patients With Renal Disease
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD 
Supportive care for patients with renal disease: Time for action
Dialysis Research and N-of-1 Trials: Made for Each Other?
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
Medication Adherence Behavior and Priorities Among Older Adults With CKD: A Semistructured Interview Study  Dena E. Rifkin, MD, MS, M. Barton Laws, PhD,
Presentation transcript:

Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study  Roberto Minutolo, MD, PhD, Francis B. Gabbai, MD, Rajiv Agarwal, MD, Paolo Chiodini, MSc, Silvio Borrelli, MD, Vincenzo Bellizzi, MD, PhD, Felice Nappi, MD, Giovanna Stanzione, MD, Giuseppe Conte, MD, Luca De Nicola, MD, PhD  American Journal of Kidney Diseases  Volume 64, Issue 5, Pages 744-752 (November 2014) DOI: 10.1053/j.ajkd.2014.06.014 Copyright © 2014 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Incidence of (A) end-stage renal disease (ESRD; in this study, defined as dialysis therapy initiation) or death, (B) fatal and nonfatal cardiovascular event, (C) ESRD, and (D) all-cause mortality in the 4 groups of patients. Group 1, patients with both clinic and ambulatory blood pressures (BPs) at goal; group 2, patients with clinic BP not at goal and ambulatory BP at goal; group 3, patients with clinic BP at goal and ambulatory BP not at goal; and group 4, patients with both clinic and ambulatory BPs not at goal. American Journal of Kidney Diseases 2014 64, 744-752DOI: (10.1053/j.ajkd.2014.06.014) Copyright © 2014 National Kidney Foundation, Inc. Terms and Conditions